Effects of dopamine agonist dose and gender on the prognosis of impulse control disorders in Parkinson's disease
Authors:
- Juho JoutsaJJJuho Joutsa
- Kirsti MartikainenKMKirsti Martikainen
- Tero VahlbergTVTero Vahlberg
- Valtteri KaasinenVKValtteri Kaasinen
- 1 December 2012
- journal article
- Published by Elsevier in Parkinsonism & Related Disorders
- Vol. 18 (10) , 1079-1083
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Frequency of impulse control behaviours associated with dopaminergic therapy in restless legs syndromeBMC Neurology, 2011
- Pathological behaviors provoked by dopamine agonist therapy of Parkinson's diseasePhysiology & Behavior, 2011
- Amantadine use associated with impulse control disorders in Parkinson disease in cross‐sectional studyAnnals of Neurology, 2010
- Impulse control disorders in patients with Parkinson's disease receiving dopamine replacement therapy: evidence and implications for the addictions fieldAddiction, 2010
- Outcomes of Patients with Parkinson Disease and Pathological GamblingCanadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques, 2010
- Long term follow-up of Parkinson's disease patients with impulse control disordersParkinsonism & Related Disorders, 2010
- Impulse Control Disorders in Parkinson DiseaseArchives of Neurology, 2010
- Clinical follow up of pathological gambling in Parkinson's disease in the West Scotland studyMovement Disorders, 2009
- Long‐term follow‐up of impulse control disorders in Parkinson's diseaseMovement Disorders, 2008
- Risk factors for pathologic gambling and other compulsions among Parkinson’s disease patients taking dopamine agonistsJournal of Clinical Neuroscience, 2007